Management of Hair Loss in Women

The 1993 document addresses the management of hair loss in women, particularly focusing on diffuse androgen-dependent alopecia and chronic telogen effluvium. It highlights the effectiveness of antiandrogens like cyproterone acetate, flutamide, and spironolactone for androgen-dependent alopecia, and the necessity of maintaining serum ferritin levels above 40 ng/mL for hair regrowth. For chronic telogen effluvium, it emphasizes the association between low serum ferritin levels and increased hair shedding, noting that levels should be raised to at least 70 ng/mL to restore normal hair proportions and reduce shedding. The document also mentions the benefits of 5% minoxidil solution and the potential of pulse electrical field therapy, while cautioning against high dosages of multivitamins that can interfere with iron absorption. It underscores the complexity of hair loss management and the importance of understanding the optimal conditions for hair growth.